Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 525
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00024180 | FR901228 in Treating Patients With Hematologic Cancer | ||
| NCT01821105 | 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer | ||
| NCT05961982 | Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study | ||
| NCT06233253 | Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy | ||
| NCT05296005 | Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers | ||
| NCT05716477 | Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patients | ||
| NCT06330805 | Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer | ||
| NCT04229381 | Resiliency Among Older Adults Receiving Lung Cancer Treatment | ||
| NCT06209619 | CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma | ||
| NCT07584239 | Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial | ||
| NCT06026657 | Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer | ||
| NCT02803333 | Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study | ||
| NCT05665725 | Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma | ||
| NCT04022616 | Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients | ||
| NCT03719092 | High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant | ||
| NCT04938869 | Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer | ||
| NCT03537599 | Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant | ||
| NCT06950008 | A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer | ||
| NCT00201760 | Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer | ||
| NCT03631641 | Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy | ||
| NCT00201799 | Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation | ||
| NCT00005864 | Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer | ||
| NCT02590497 | Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery | ||
| NCT07723235 | Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial | ||
| NCT05401097 | IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study) | ||
| NCT05802797 | Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules | ||
| NCT01681901 | Ultrasound in Detecting Lymph Node Metastasis in Older Patients Undergoing Breast Sonography | ||
| NCT03532581 | Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery | ||
| NCT01219777 | Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian | ||
| NCT02944565 | Daratumumab in Treating Patients With Multiple Myeloma | ||
| NCT00293579 | Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer | ||
| NCT02677961 | An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry | ||
| NCT02791737 | Exercise Prehab in Older Adults With Hematologic Malignancies | ||
| NCT01408225 | Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource | ||
| NCT06223659 | EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers | ||
| NCT01692340 | Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans | ||
| NCT02445378 | Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy | ||
| NCT05873712 | Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome | ||
| NCT02518555 | Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ||
| NCT00230126 | OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer | ||
| NCT01460940 | A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma | ||
| NCT02788708 | Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer | ||
| NCT02093403 | Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT07705919 | DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer | ||
| NCT01478477 | Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole | ||
| NCT06424522 | A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients | ||
| NCT06536049 | Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | ||
| NCT05677802 | Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer | ||
| NCT06112002 | Evaluation of an Education Program to Increase Knowledge and Participation in Clinical Trials Among Racial/Ethnic and Rural Populations | ||
| NCT03552471 | Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
